And the man’s mother in tears recalling her son, a Boston police officer whose death is at the heart of a trial gripping the nation. The first full day of testimony concluded on Wednesday.

Prosecutors want to seal Sean Combs' "freak off" videos in sex-trafficking trial. Combs is accused of sex trafficking and racketeering, with Cassie Ventura as a key victim. The judge is hammering ...

LONDON, Ont.—A new 14-person jury will hear the case of five professional hockey players accused of sexual assault after a judge declared a mistrial and dismissed the previous jury on Friday.

Karen Read’s second trial in connection with the death of her boyfriend, Boston police officer John O’Keefe, continued on Thursday in Dedham’s Norfolk Superior Court before Judge Beverly ...

The High Court in Bloemfontein has postponed the asbestos case to the fifth of next month for the start of a trial-within-a-trial. Judge Phillip Loubser this morning granted former Free State Premier ...

PIETERMARITZBURG - Former president Jacob Zuma has lost another round in his fight to have prosecutor Billy Downer removed from his arms deal corruption trial.

NEW YORK – Sean "Diddy" Combs was back in court April 25 before his federal sex crimes trial begins May 5. Less than two weeks before the trial kicks off, Combs' attorneys met with Judge Arun ...

The murder trial for the former Illinois sheriff's deputy who shot and killed Sonya Massey last year has been scheduled for October. A judge on Wednesday scheduled former Sangamon County Sheriff's ...

King’s College London scientists say the first trial of the therapy in adults has shown “great success”. Two thirds of patients were able to eat the equivalent of five peanuts with no ...

NEWPORT NEWS, Va. (WAVY) — The Richneck Elementary School assistant principal charged in connection to the 2023 shooting of teacher Abby Zwerner by a 6-year-old student will have to wait a ...

A groundbreaking AI-powered blood test that detects 12 cancers from a tiny sample is entering NHS trials.

Akeso and Summit Therapeutics’ giant-killing, PD-1xVEGF bispecific antibody ivonescimab has posted another phase 3 trial win in lung cancer, this time as part of a chemotherapy combination.